US2009048172A1PendingUtilityA1
Neuroprotective dietary supplement
Est. expiryJan 29, 2024(expired)· nominal 20-yr term from priority
A61P 43/00A61P 25/28A61P 25/00A23L 33/175A61K 38/10A23L 33/18A23L 33/00A61K 38/04A61K 38/08
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to a novel dietary supplement mixture having improved neuroprotective activity and preventing, ameliorating or counteracting neurodegeneration and preventing, counteracting and/or improving cognitive function decline. It also provides a dietary supplement, which is to be administered in an oral dosage form.
Claims
exact text as granted — not AI-modified1 ) Dietary supplement mixture having neuroprotective activity which comprises a peptide formulation, comprising at least one of the two peptides defined by sequence 1: NMVPFPR or sequence 2: ASAFQGIGSTHWVYDGVGNS.
2 ) Dietary supplement mixture according to claim 1 further comprising additional amino acids.
3 ) Dietary supplement mixture according to claim 1 comprising further peptides with a molecular weight less than 10 kDa.
4 ) Dietary supplement mixture according to claim 1 comprising trace elements and/or mineral substances and/or vitamins and/or caffeine and/or taurine and/or fatty acids and/or phospholipids, and/or phosphatidylserines and/or plant extracts.
5 ) Dietary supplement mixture according to claim 1 further comprising acceptable additives and/or excipients and/or fillers and/or colouring substances and/or flavouring substances.
6 ) Oral dosage form comprising a dietary supplement mixture according to one of claims 1 - 5 and acceptable additives and/or excipients and/or fillers and/or colouring substances and/or flavouring substances and/or solvents.
7 ) Oral dosage form comprising a dietary supplement mixture according to claim 1 , comprising 2-20 wt % peptides.
8 ) Oral dosage form according to claim 7 further comprising 10-30 wt % amino acids.
9 ) Use of the dietary supplement mixture according to one of the claims 1 - 8 , for preventing, ameliorating or improving age-associated memory impairment and/or age-associated cognitive decline and/or benign senescent forgetfulness.
10 ) Use of the dietary supplement mixture according to one of the claims 1 - 5 , to protect neurons against metabolic deficits and stress associated with aging processes.
11 ) Use of the dietary supplement mixture according to one of the claims 1 - 5 , to prevent, counteract and/or ameliorate the consequences of age-related neuronal lesions due to hypoxia or ischaemia, the consequences of age-related neuronal lesions due to intracellular calcium overload, the consequences of age-related neuronal lesions induced by L-glutamate and excitotoxic events and the consequences of age-related neuronal lesions due to oxidative stress.
12 ) Use of the dietary supplement mixture according to one of the claims 1 - 5 , to prevent, counteract and/or ameliorate the consequences of age-associated neurodegeneration, to prevent neuronal cell death due to cell stress, neurodegenerative events and intoxication, to maintain and preserve normal neuronal cytoarchitecture during aging processes, to support and/or improve synaptic function and synaptic density, to prevent, counteract, and or ameliorate the consequences of the age-related decline of synaptic plasticity and of synaptic density.
13 ) Use of the dietary supplement mixture according to one of the claims 1 - 5 , to activate cerebral mechanisms related to attention and memory performance.
14 ) Use of the dietary supplement mixture according to one of the claims 1 - 5 , to prevent, counteract, and/or improve cognitive function decline, to prevent, counteract, and/or improve memory function decline, to prevent, counteract, and/or improve attention deficits, to prevent, counteract, and/or improve a decrease of vigilance associated with aging processes and to support, maintain and or improve long term memory and procedural memory as well as learning performance, attention and vigilance.
15 ) Use of the dietary supplement mixture according to one of the claims 1 - 5 , to preserve/support healthy mental function during the aging processes.Join the waitlist — get patent alerts
Track US2009048172A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.